申请人:Singh Rajinder
公开号:US20050215614A1
公开(公告)日:2005-09-29
The present invention comprises indole-derivatives that are inhibitors of HCV. Composition comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
本发明涉及一种抑制HCV的吲哚衍生物。还公开了包含该化合物与药用载体组合的组合物,以及使用该化合物和组合物抑制细胞中的HCV感染的方法,特别是用于治疗哺乳动物中的HCV感染。